{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:15:13Z","timestamp":1792185313578,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":104,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA TR 000471-01"],"award-info":[{"award-number":["ZIA TR 000471-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA TR 000053"],"award-info":[{"award-number":["ZIA TR 000053"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA274329"],"award-info":[{"award-number":["U54CA274329"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA256911"],"award-info":[{"award-number":["R01CA256911"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA270234"],"award-info":[{"award-number":["R01CA270234"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA BC 009287"],"award-info":[{"award-number":["ZIA BC 009287"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA163649"],"award-info":[{"award-number":["R01CA163649"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.chembiol.2023.09.014","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T10:27:10Z","timestamp":1698056830000},"page":"221-233.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Methotrexate-based PROTACs as DHFR-specific chemical probes"],"prefix":"10.1016","volume":"31","author":[{"given":"Sandeep","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Dranchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayme L.","family":"Dahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Oliphant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Shrimp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish H.","family":"Rajacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Tharakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apryl S.","family":"Whitten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott K.","family":"Durum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesha","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Inglese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2023.09.014_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib2","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.1780351113","article-title":"The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate","volume":"35","author":"Hoffman","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.chembiol.2023.09.014_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","article-title":"Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance","volume":"15","author":"Gonen","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.chembiol.2023.09.014_bib4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI112088","article-title":"Polyglutamation of methotrexate. Is methotrexate a prodrug?","volume":"76","author":"Chabner","year":"1985","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chembiol.2023.09.014_bib5","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1016\/S0021-9258(18)68734-4","article-title":"Gene amplification in cultured cells","volume":"263","author":"Schimke","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V86.2.677.bloodjournal862677","article-title":"Amplification of the Dihydrofolate-Reductase Gene Is a Mechanism of Acquired-Resistance to Methotrexate in Patients with Acute Lymphoblastic-Leukemia and Is Correlated with P53 Gene-Mutations","volume":"86","author":"Goker","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.chembiol.2023.09.014_bib7","first-page":"2227","article-title":"Acquisition of Resistance to Antifolates Caused by Enhanced Gamma-Glutamyl Hydrolase Activity","volume":"53","author":"Rhee","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2023.09.014_bib8","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/sj.leu.2404692","article-title":"ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?","volume":"21","author":"Steinbach","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.chembiol.2023.09.014_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0021-9258(17)34960-8","article-title":"Pteroylaspartic Acid, an Antagonist for Pteroylglutamic Acid","volume":"170","author":"Hutchings","year":"1947","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib10","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1021\/jm00257a015","article-title":"Methotrexate Analogs .3. Synthesis and Biological Properties of Some Side-Chain Altered Analogs","volume":"17","author":"Chaykovsky","year":"1974","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/jm00251a022","article-title":"Synthesis and antifolate activity of 10-deazaminopterin","volume":"17","author":"DeGraw","year":"1974","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib12","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/jm00258a016","article-title":"Methotrexate analogs. 4.7-Methyl derivatives of methotrexate and dichloromethotrexate. A new synthesis and some biological studies","volume":"17","author":"Rosowsky","year":"1974","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1021\/jm00202a013","article-title":"Methotrexate analogues. 11. Unambiguous chemical synthesis and in\u00a0vitro biological evaluation of alpha- and gamma-monoesters as potential prodrugs","volume":"21","author":"Rosowsky","year":"1978","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib14","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1021\/jm970085n","article-title":"Synthesis and evaluation of novel fluorinated methotrexate derivatives for application to rheumatoid arthritis treatment","volume":"40","author":"Kokuryo","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib15","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1073\/pnas.82.9.2598","article-title":"gamma-Fluoromethotrexate: synthesis and biological activity of a potent inhibitor of dihydrofolate reductase with greatly diminished ability to form poly-gamma-glutamates","volume":"82","author":"Galivan","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.09.014_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1021\/jm00125a002","article-title":"A multisubstrate adduct inhibitor of a purine biosynthetic enzyme with a picomolar dissociation constant","volume":"32","author":"Inglese","year":"1989","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/jm00193a022","article-title":"Methotrexate analogues. 12. Synthesis and biological properties of some aza homologues","volume":"22","author":"Martinelli","year":"1979","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1021\/jm00193a021","article-title":"Analogues of methotrexate","volume":"22","author":"Montgomery","year":"1979","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/med.2610080106","article-title":"The chemistry of methotrexate and its analogues","volume":"8","author":"Rahman","year":"1988","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.chembiol.2023.09.014_bib20","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.09.014_bib21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccell.2019.10.002","article-title":"A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In\u00a0Vivo","volume":"36","author":"Bai","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2023.09.014_bib22","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1039\/C7CC03879H","article-title":"Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)","volume":"53","author":"Robb","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.chembiol.2023.09.014_bib23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.bmcl.2019.03.035","article-title":"Selective degradation of CDK6 by a palbociclib based PROTAC","volume":"29","author":"Rana","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2023.09.014_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128061","article-title":"Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax","volume":"43","author":"King","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2023.09.014_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2023.09.014_bib26","doi-asserted-by":"crossref","first-page":"17019","DOI":"10.1021\/jacs.8b08008","article-title":"Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation","volume":"140","author":"Cromm","year":"2018","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2023.09.014_bib27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.chembiol.2012.04.008","article-title":"Inhibitor mediated protein degradation","volume":"19","author":"Long","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib28","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1021\/acschembio.8b00390","article-title":"Revisiting the \"Art of the Chemical Probe","volume":"13","author":"Schwarz","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","article-title":"Hijacking the E3\u00a0Ubiquitin Ligase Cereblon to Efficiently Target BRD4","volume":"22","author":"Lu","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib30","doi-asserted-by":"crossref","first-page":"9467","DOI":"10.1021\/bi00492a021","article-title":"Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate","volume":"29","author":"Davies","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2023.09.014_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/17460441.2011.537322","article-title":"Fluorescence polarization assays in small molecule screening","volume":"6","author":"Lea","year":"2011","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.chembiol.2023.09.014_bib32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/jm00239a020","article-title":"Synthesis of a Fluorescent Derivative of Amethopterin","volume":"18","author":"Gapski","year":"1975","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib33","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/bi00579a021","article-title":"Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase","volume":"18","author":"Williams","year":"1979","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2023.09.014_bib34","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.172501499","article-title":"Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics","volume":"99","author":"Rajagopalan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.09.014_bib35","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1039\/D3CC02540C","article-title":"Firefly luciferin methyl ester illuminates the activity of multiple serine hydrolases","volume":"59","author":"Mohammad","year":"2023","journal-title":"Chem. Commun."},{"key":"10.1016\/j.chembiol.2023.09.014_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2023.09.014_bib37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","article-title":"NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells","volume":"11","author":"Dixon","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib38","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1021\/acschembio.0c00343","article-title":"High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle","volume":"15","author":"Kinder","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib39","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1073\/pnas.58.4.1632","article-title":"Increase of Dihydrofolate Reductase Activity in Cultured Mammalian Cells after Exposure to Methotrexate","volume":"58","author":"Hillcoat","year":"1967","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.09.014_bib40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tips.2020.02.006","article-title":"Critical Assessment of Targeted Protein Degradation as a Research Tool and Pharmacological Modality","volume":"41","author":"Kostic","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.chembiol.2023.09.014_bib41","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/bph.15014","article-title":"Proteolysis-targeting chimeras in drug development: A safety perspective","volume":"177","author":"Moreau","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","article-title":"Targeted protein degradation: elements of PROTAC design","volume":"50","author":"Paiva","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molcel.2009.12.024","article-title":"Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in\u00a0situ","volume":"37","author":"Brownell","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2023.09.014_bib44","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nchembio.1858","article-title":"Catalytic in\u00a0vivo protein knockdown by small-molecule PROTACs","volume":"11","author":"Bondeson","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib45","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/acschembio.7b00116","article-title":"Selective Downregulation of JAK2 and JAK3 by an ATP-Competitive pan-JAK Inhibitor","volume":"12","author":"Field","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib46","doi-asserted-by":"crossref","first-page":"12317","DOI":"10.1021\/bi971026e","article-title":"Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region","volume":"36","author":"Ercikan-Abali","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2023.09.014_bib47","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.chembiol.2023.09.014_bib48","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1038\/sj.onc.1204436","article-title":"Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms","volume":"20","author":"Belmokhtar","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2023.09.014_bib49","first-page":"586","article-title":"Mechanism of growth inhibition by methotrexate","volume":"35","author":"McBurney","year":"1975","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2023.09.014_bib50","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1038\/sj.onc.1206946","article-title":"Resistance to antifolates","volume":"22","author":"Zhao","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2023.09.014_bib51","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1021\/acs.analchem.1c00265","article-title":"A Universal and High-Throughput Proteomics Sample Preparation Platform","volume":"93","author":"Burns","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chembiol.2023.09.014_bib52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/3-7643-7414-4_11","article-title":"Preclinical development of Alimta (Pemetrexed, LY231514), a multitargeted antifolate","volume":"63","author":"Schultz","year":"2005","journal-title":"Prog. Drug Res."},{"issue":"Pt 1","key":"10.1016\/j.chembiol.2023.09.014_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/bj3420143","article-title":"Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?","volume":"342","author":"Fairbanks","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.chembiol.2023.09.014_bib54","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41375-021-01189-2","article-title":"Folate metabolism: a re-emerging therapeutic target in haematological cancers","volume":"35","author":"Zarou","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.chembiol.2023.09.014_bib55","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a Cancer Dependency Map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2023.09.014_bib56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ddtec.2019.02.002","article-title":"A critical evaluation of the approaches to targeted protein degradation for drug discovery","volume":"31","author":"Chopra","year":"2019","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108532","article-title":"Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins","volume":"34","author":"Shirasaki","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.chembiol.2023.09.014_bib58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cell.2007.01.021","article-title":"Chemical genetics: where genetics and pharmacology meet","volume":"128","author":"Knight","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2023.09.014_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101512","article-title":"RNA interference protocol to silence oncogenic drivers in leukemia cell lines","volume":"3","author":"Beyer","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.chembiol.2023.09.014_bib60","doi-asserted-by":"crossref","first-page":"D442","DOI":"10.1093\/nar\/gky1106","article-title":"The PRIDE database and related tools and resources in 2019: improving support for quantification data","volume":"47","author":"Perez-Riverol","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2023.09.014_bib61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature04687","article-title":"A loss-of-function RNA interference screen for molecular targets in cancer","volume":"441","author":"Ngo","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2023.09.014_bib62","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/0006-2952(83)90047-3","article-title":"A mechanism of resistance to methotrexate. NADPH but not NADH stimulation of methotrexate binding to dihydrofolate reductase","volume":"32","author":"Kamen","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib63","series-title":"Assay Guidance Manual","article-title":"Minimum Significant Ratio - A Statistic to Assess Assay Variability","author":"Haas","year":"2004"},{"key":"10.1016\/j.chembiol.2023.09.014_bib64","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nchembio0807-438","article-title":"Reporting data from high-throughput screening of small-molecule libraries","volume":"3","author":"Inglese","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.09.014_bib65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrc.2017.32","article-title":"Common pitfalls in preclinical cancer target validation","volume":"17","author":"Kaelin","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.chembiol.2023.09.014_bib66","doi-asserted-by":"crossref","first-page":"15073","DOI":"10.1021\/jacs.1c04841","article-title":"Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation","volume":"143","author":"Wei","year":"2021","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2023.09.014_bib67","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ccell.2017.08.008","article-title":"MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer","volume":"32","author":"Shukla","year":"2017","journal-title":"Cancer Cell"}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945623003331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945623003331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:52:10Z","timestamp":1778889130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945623003331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2451945623003331"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2023.09.014","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate-based PROTACs as DHFR-specific chemical probes","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2023.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}